“Safety and Efficacy of Bivalirudin in Diabetic Acute Coronary Syndrome (ACS) Patients Undergoing Percutaneous Coronary Intervention (PCI)” (2021) European Journal of Medical and Health Sciences, 3(2), pp. 93–97. doi:10.24018/ejmed.2021.3.2.768.